Inhaler monitoring company Adherium has announced that its Smartinhaler platform has been rebranded as “Hailie.” The rebranding includes includes the Hailie asthma and COPD tracking app and Hailie sensors, which will soon launch in the US. Earlier this year, the FDA granted 510(k) OTC clearance for the Smartinhaler SmartTouch sensor for use with Symbicort.
The company is also launching a data reporting website for clinicians and other healthcare providers that Adherium says “will support engagement between healthcare professionals and patients by enabling sharing and monitoring of patient inhaler usage.”
Adherium CEO Arik Anderson commented, “We’re extremely excited to announce the Hailie brand. It encompasses the world’s most clinically proven asthma and COPD medication adherence solution and represents an evolution of our business. Our technology, which is supported by 15 years of research and development, will soon be available directly to patients for the first time ever in the US.”
VP of Marketing Vik Panda said, “With more and more patients leveraging technology for not just tracking fitness but overall health, we want to give them a personified brand like Hailie that they can identify with,. Hailie is your asthma and COPD sidekick, always there to support you and help you manage your condition.”
Read the Adherium press release.
